Decreased sexual risk behaviour after the diagnosis of HIV and initiation of antiretroviral treatment - a study of patients in Johannesburg by Fougelberg, J et al.
december 2006                                        THE SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE    12
THE FREE HIV TREATMENT PROGRAMME
IN SOUTH AFRICA
An extended free antiretroviral treatment (ART) programme 
was launched in April 2004, as part of the Comprehensive
National Plan on HIV and AIDS Care, Management and
Treatment. The aim is to provide access to antiretroviral
treatment to more than 1.4 million South Africans by 2008. 
The primary goals of the free treatment programme are to
diminish HIV/AIDS-related deaths and to decrease the
incidence of HIV-related opportunistic infections. Another
goal is to decrease the incidence of HIV. It is hoped that this
target will be met thanks to an increase in voluntary testing
and counselling, which will lead to more people knowing
about their status and practising safer sex. Further, it is
envisaged that HIV prevalence in children will decrease
because of prevention of mother-to-child transmission. 
METHOD
The study was conducted between 17 January and 22 February
2005 at the HIV clinic at Helen Joseph Hospital in
Johannesburg, South Africa.
The inclusion criteria for the study were:
■ Age over 18 years
■ HIV positive
■ Having received ART for 4 - 12 months
■ Agreement to participate in the study.
After ethics approval was sought from the Human Research
and Ethics Committee of the University of the Witwatersrand
and the patients had signed for consent, they were asked to
answer a questionnaire.  The questionnaire consisted of 21
questions concerning age, sex, level of education, time since
diagnosis of HIV, reason for HIV test, disclosure of HIV status
P R E V E N T I O N
Decreased Sexual Risk Behaviour 
after the diagnosis of HIV and
Initiation of Antiretroviral
Treatment  –  a study of patients 
in Johannesburg
Julia Fougelberg, Medical Student
Sofie Karlström, Medical Student
Department of Infectious Diseases, Sahlgrenska Academy, Göteborg University, Gothenburg, Sweden
Yosuf Veriava, MB BCh, FCP (SA), FRCP (Lond)
Prudence Ive, MB BCh, FCP (SA)
Helen Joseph Hospital, Johannesburg, South Africa
Rune Andersson, PhD, MD
Department of Infectious Diseases, Sahlgrenska Academy, Göteborg University, Gothenburg, and Research and Development Centre,
Skaraborg Hospital, Skövde, Sweden
Objectives. An extended programme for free antiretroviral treatment (ART) of HIV was launched in South Africa in April 2004.
It is essential to assess the effects on sexual risk behaviour.
Design and setting. A questionnaire was distributed to patients on ART at Helen Joseph Hospital, Johannesburg, between 17
January and 22 February 2005.
Results. The percentage of men who had sexual contacts outside their relationship decreased from 48% before HIV diagnosis
to 11% after starting ART. Condom use with casual partners increased from 53% among the men and 46% among the women
before the diagnosis of HIV to 87% and 81% respectively on ART.
The majority of patients were tested for HIV because they presented with symptoms of illness. We noted no significant
difference in disclosure rate after the start of ART. All participants were positive about the treatment and felt physically better.
The majority of the patients experienced a better quality of life.
Conclusions. The ART had an overall positive effect on health with no increase of sexual risk behaviour.
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before and after ART, HIV test of partner and children,
adherence to ART, subjective effects of ART, and number of
partners and use of condoms before HIV test, between HIV test
and ART and during ART. The information sheet and
questionnaire were in English, and patients who had
difficulties in speaking English were excluded. 
All data were handled confidentially. Each questionnaire was
registered with a number linked to a confidential list of patient
names, to which only the research group had access.
STATISTICAL METHODS
The following formula was used for calculating 95%
confidence intervals(CIs): SEM (p) = √(p*(100-p))/n; 95% CI =
p +/- SEM(p)*1.96 are used. The formula is applicable when
p*n ≥ 500 and (100-p)*n ≥ 500. (p = proportion in %, n =
number of observations, SEM = standard error of the mean.1)
For proportions where the formula was not applicable, the CIs





A total of 123 patients participated. Sixty-nine per cent were
women compared with 31% men (p < 0.01). The mean age was
35.1 years (men 33.7 years, women 35.7 years). The median
age was 34 years. 
The reason for HIV testing was a general feeling of illness for
61% of the men and 53% of the women. Twenty-six per cent
of the men and 9% of the women were tested because they
had an HIV-positive partner, and 20% of the women were
tested as part of routine pregnancy testing.
Education
Fifty-seven per cent of the participants had secondary school
as their highest level of education. There were more men than
women with university or college degrees (28% v. 9%), as well
as a higher percentage of non-educated men (16% v. 9%).
None of these differences were statistically significant. The
exclusion of patients who did not speak English means that
patients with limited education did not participate in the
study. A few patients who could not read English were assisted
by the study team. 
Partner and children
Seventy per cent of the men and 59% of the women reported
that they had a current partner (NS). There were only two
options to choose from in the question about partnership
(partner/no partner). There was no choice for widows.
Ninety-one per cent of the women and 76% of the men had
children (NS). The average number of children was 2.1 for men
and 2.4 for women. Number of children ranged from 1 to 7.
Eighty-three per cent of the men and 73% of the women
reported that their partner has been tested for HIV (NS). There
was a tendency towards the female group having been
diagnosed a longer time ago than the male group. Fifty-eight
per cent of the women and 27% of the men had had their HIV
test more than 2 years ago (p < 0.01).
Disclosure
Before the start of treatment 18% (95% CI 6.1 - 34.3) of the
men and 9% (95% CI 3.2 - 17.7) of the women had disclosed
their HIV status to no one. 
After the start of ART, 64% of the men and 51% of the women
had told their partners (NS).
As demonstrated in Figs 1 and 2, men and women reached the
same level of disclosure to sisters/brothers and friends, but
more disclosures for men to friends were noted after start of
ART (p < 0.05). 
Antiretroviral treatment
The first-line treatment was stavudine + lamivudine +
efavirenz or nevirapine. The second-line treatment was
zidovudine + didanosine + lopinavir/ritonavir.
The duration of the treatment ranged from 4 to 12 months.
Both mean and median numbers were higher for women than
for men (6.6 and 6, 5.9 and 5 months). 
Sexual behaviour
Fifty per cent of the men and 40% of the women believed they
were more infectious to others after the start of treatment
(NS). Only 13% in both groups thought they were less
infectious, the correct answer.
More men than women had sexual contacts outside their
relationship before they were aware of their status (p < 0.05).
For the men we noted a tendency towards a decrease of these
Fig. 1. Disclosure of HIV status among 38 men.
Fig. 2. Disclosure of HIV status among 85 women.
Who have you told that you are HIV positive?
Who have you told that you are HIV positive?
After start of treatment
Before start of treatment
After start of treatment
Before start of treatment
Partner Parent Children Friends OthersSister/brother







































december 2006                                        THE SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE    14
contacts after diagnosis being significant (p < 0.05) after the
start of ART. The number of women who had sex outside their
relationship remained constant during the three periods
(Table I).
Use of condoms during sexual contact, both with regular
partners and casual partners, increased significantly during
ART compared with before HIV diagnosis (p < 0.05) (Tables II
and III).
As many as 45% of the women said that they had never had
sex with a men who used a condom, and 25% of the men that
they had never used a condom. 
DISCUSSION
We noted a tendency towards women having been aware of
their HIV infection for a longer time than men. This may be
explained by the belief that women are generally more
concerned about their health than men. Many women also
find out that they are HIV positive when they are pregnant;
this often results in their finding out their status before they
become symptomatic. Another possible explanation is that the
peak of the epidemic differs for men and women. 
Only 64% of the men and 51% of the women had disclosed
their HIV status to their partner. Causes for the low disclosure
rate might be stigma and fear of being abandoned, or that
they no longer have contact with a former partner. There
seemed to be no significant difference in levels of disclosure
after the start of treatment, which is in agreement with recent
studies from Johannesburg and Swaziland.2,3
SEXUAL BEHAVIOUR
One of the most surprising findings in this study was that so
many of the participants (50% of the men and 40% of the
women) thought that they were more infectious after starting
their treatment. Only a few thought that they were less
infectious, which is the correct scientific response. One
explanation may be that the patients were informed that it is
even more important, now that they are on treatment, to use
condoms to prevent exchange of resistant strains. 
More men than women had sexual contacts outside their
relationship before their diagnosis. The number of men who
stated they had sex outside their relationship decreased as
their treatment progressed. We did not see this pattern among
women.
For both sexes use of condoms increased after the start of
treatment compared with before diagnosis of HIV. This
contrasts with the findings from a study of sexual risk
behaviour in HIV-positive injection drug users in Baltimore,
USA, which demonstrated a threefold increase in unprotected
sexual intercourse after HAART initiation.4 The outcome of our
study is similar to the findings in a meta-analytic review.5
Sexual contacts Before diagnosis After diagnosis but before treatment After start of treatment
outside relationship Men Women Men Women Men Women
N 32 82 33 79 33 78
Frequency 48% 17% 21% 16% 11% 13%
95% CI 31 - 65% 11 - 25% 7 - 35% 8 - 24% 0 - 22% 6 - 20%
Use of condoms in Before HIV diagnosis After diagnosis but before start of treatment After start of treatment
regular relationship Men Women Men Women Men Women
N 37 83 37 80 37 80
Frequency 25% 29% 38% 57% 72% 75%
95% CI 11 - 39% 19 - 39% 22 - 54% 46 - 68% 58 - 86% 66 - 84%
TABLE II. USE OF CONDOMS IN REGULAR RELATIONSHIP
Use of condoms with Before HIV diagnosis After diagnosis but before start of treatment After start of treatment
casual partner Men Women Men Women Men Women
N 37 82 37 78 36 79
Frequency 53% 46% 66% 69% 87% 81%
95% CI 37 - 69% 34 - 58% 51 - 81% 59 - 79% 76 - 98% 72 - 90%
TABLE III. USE OF CONDOMS WITH CASUAL PARTNER
TABLE I. SEXUAL CONTACTS OUTSIDE RELATIONSHIP
A study of sexual risk behaviour based on a simple
questionnaire has several shortcomings. It is based on self-
reported behaviour which can not be confirmed by objective
data. However, our results do not support the suggested
increase of risk behaviour in connection with ART.
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